Method of treating condition in animal

Details Method of treating condition in animal Method of treating condition in animal

2007-03-02

2010-12-28

Kosar, Andrew D (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

07858586

ABSTRACT:
The invention relates to compositions comprising of SEQ NO: 1-244, 248-249, and any homologs, analogs, and fragments thereof. Such compositions can be used to treat, prevent, and modulate pain, inflammation, and metabolic processes in various organisms including plants and animals. Such compositions can be formulated with an acceptable pharmaceutical excipient for administration to a human or a plant. The compositions can be administered topically or for systemic use.

REFERENCES:
patent: 5189064 (1993-02-01), Blum et al.
patent: 5328836 (1994-07-01), Shima et al.
patent: 5492894 (1996-02-01), Bascom et al.
patent: 5506202 (1996-04-01), Vertesy et al.
patent: 5705621 (1998-01-01), Ravikumar
patent: 5760044 (1998-06-01), Archer
patent: 5854226 (1998-12-01), Penkler et al.
patent: 6419931 (2002-07-01), Vitiello et al.
patent: 6689363 (2004-02-01), Sette et al.
patent: 6794144 (2004-09-01), Saksela et al.
patent: 6849714 (2005-02-01), Bridon et al.
patent: 7244599 (2007-07-01), Tanner et al.
patent: 7557088 (2009-07-01), Skubatch
patent: 2004/0254343 (2004-12-01), Miyakaki et al.
patent: 2006/0154863 (2006-07-01), Skubatch
patent: 2007/0254811 (2007-11-01), Skubatch
patent: 2007/0259818 (2007-11-01), Skubatch
patent: 2009/0069237 (2009-03-01), Skubatch
patent: 2009/0170784 (2009-07-01), Skubatch
patent: 2010/0137227 (2010-06-01), Skubatch
patent: 4433564 (1996-04-01), None
patent: 0514268 (1992-11-01), None
patent: 0966975 (1999-12-01), None
patent: 0966975 (2002-04-01), None
patent: 0966975 (2005-09-01), None
patent: 6-107683 (1994-04-01), None
patent: WO 97/44447 (1997-11-01), None
patent: WO 97/44447 (1997-11-01), None
patent: WO 00/54805 (2000-09-01), None
patent: WO 00/69900 (2000-11-01), None
patent: WO 00/69900 (2000-11-01), None
patent: WO 02/19986 (2002-03-01), None
patent: WO 02/060432 (2002-08-01), None
patent: WO 02/066625 (2002-08-01), None
patent: WO 03/006654 (2003-01-01), None
patent: WO 03/006654 (2003-10-01), None
patent: WO 2004/054614 (2004-07-01), None
patent: WO 2004/058804 (2004-07-01), None
patent: WO 2004/098644 (2004-11-01), None
patent: WO 2004/099135 (2004-11-01), None
patent: WO 2004/099135 (2004-11-01), None
patent: WO 2004/101797 (2004-11-01), None
patent: WO 2006/000034 (2006-01-01), None
patent: WO 2006/006172 (2006-01-01), None
patent: WO 2006/006172 (2006-05-01), None
patent: WO 2006/045313 (2006-05-01), None
patent: WO 2006/045314 (2006-05-01), None
patent: WO 2006/045314 (2006-05-01), None
patent: WO 2006/045319 (2006-05-01), None
patent: WO 2006/068768 (2006-06-01), None
patent: WO 2006/068768 (2006-06-01), None
patent: WO 2006/045313 (2006-08-01), None
patent: WO 2006/045319 (2006-09-01), None
H. Unlugenc et al. Br. J. Anaest. (2003) 91(2), pp. 209-213.
J. Reimer-Kent. Am. J. Crit. Care. (2003) 12(2), pp. 136-143.
U.J. Moore et al. Br. J. Clin. Pharmacol. (1994) 37(3), pp. 227-230.
E.A. Kiyatkin and R.A. Wise. J. Neurosci. (2002) 22(3), pp. 1072-1080.
K. Lufty et al. Psychopharm. (2002) 164, pp. 168-176.
J. Gimbel and H. Ahdieh. Anesth. Analg. (2004) 99, pp. 1472-1477.
Chen, et al. Epsin is an EH-domain-binding protein implicated in clathrin-mediated endocytosis. Nature. 1998; 394:793-7.
Dinkova-Kostova, A., et al. (+)-Pinoresinol/(+)-Lariciresinol Reductase from Forsythia Intermedia. J. Biol. Chem. 1996; 271(46):29473-82.
Fujita, et al. Recombinant pinoresinol-lariciresinol reductases from western red cedar (Thuja plicata) catalyze opposite enantiospecific conversions. J. Biol. Chem. 1999; 274(2):618-27.
Gang, D. et al. Evolution of Plant Defense Mechanism. J. Biol. Chem. 1999; 274(11):7516-7527.
Horikawa, et al. Isolation and structural organization of the human preproenkephalin B gene. Nature. 1983; 306:611-4.
Latvala-Kilby, et al. The complete nucleotide sequence of RNA2 of blackcurrant reversion nepovirus. Virus Research. 1999; 65:87-92.
Lers, et al. The expression of a grapefruit gene encoding an isoflavone reductase-like protein is induced in response to UV irradiation. Plant Mol. Biol. 1998; 36:847-56.
Messer, W. S. Vasopressin and Oxytocin. This page was last updated on Monday, Apr. 3, 2000. Available at http://www.neurosci.pharm.utoledo.edu/MBC3320/vasopressin.htm. Accessed Dec. 19, 2006.
NCBI Database Accession No. AAC50454, Feb. 28, 2006.
NCBI Database Accession No. AAD09329, Feb. 28, 2006.
NCBI Database Accession No. NP—001017915, Feb. 28, 2006.
NCBI Database Accession No. NP—005532, Feb. 28, 2006.
Shorter, et al. GRASP55, a second mammalian GRASP protein involved in the stacking ofGolgi cisternaein a cell-free system. EMBO J. 1999; 18(18):4949-60.
Bertoletti, et al. Definition of minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. J Virol. 1993;67(4):2376-80.
Hawks, et al. Opioid Peptids. Drug Abuse Research Monograph. # 70, 1986.
Hruby, et al. Design of novel peptide ligands which have opioid agonist activity and CCK antagonist activity for the treatment of pain. 2003; 73:699-704.
Hruby, et al. Conformation-activity relationships of opioid peptides with selective activities at opioid receptors. Biopolymers. 1999; 51(6):391-410.
McPherson. A comparison of salts for the crystallization of macromolecules. Protein Sci. 2001; 10(2):418-22.
Pikal, et al. The stability of insulin in crystalline and amorphous solids: observation of greater stability for the amorphous form. Pharm Res. 1997; 14(10):1379-87.
Shenoy, et al. Stability of crystalline proteins. Biotechnol Bioeng. 2001; 73(5):358-69.
International search report dated Oct. 29, 2008 for PCT Application No. US2008/064171.
International search report dated Nov. 13, 2007 for PCT Application No. US2005/42682.
International search report dated Feb. 10, 2009 for PCT Application No. US2008/70534.
International search report dated Sep. 29, 2008 for PCT Application No. US2007/65404.
Keinath, et al. Evaluation of biological and chemical seed treatments to improve stand of snap bean across the southern United States. Crop Protection. 2000; 19(7):501-509.
Larkindale, et al. Protection against Heat Stress-Induced Oxidative Damage in Arabidopsis Involves Calcium, Abscisic Acid, Ethylene, and Salicylic Acid. Plant Physiol, Feb. 2002, vol. 128, pp. 682-695.
Syamsuwida, et al. Time and method of floral initiation and effect of paclobutrazol on flower and fruit development inShorea stenoptera(Dipterocarpaceae). Tree Physiol. Apr. 1997;17(4):211-9.
Weiss, et al. A tricyclic ring system replaces the variable regions of peptides presented by three alleles of human MHC class I molecules. Chem Biol. Jun. 1995;2(6):401-7.
Salzet, M. Neuroimmunology of opioids from invertebrates to human. Neuro Endocrinol Lett. Dec. 2001;22(6):467-74.
Catania, et al. Peptide modulation of fever and inflammation within the brain. Ann N Y Acad Sci. Sep. 29, 1998;856:62-8.
Emel'ianova, et al. Effect of dermorphin analogs on thermoregulation of rats under various thermal conditions. Biology Bulletin. 2002; 29(3):284-289. (Translated from Izv Akad Nauk Ser Biol. May-Jun. 2002;(3):348-54.).
European search report dated Jun. 7, 2010 for Application No. 5852156.8.
Kalliomaki, et al. Prolactin-releasing peptide affects pain, allodynia and autonomic reflexes through medullary mechanisms. Neuropharmacology. Mar. 2004;46(3):412-24.
Le Guen, et al. Pain management by a new series of dual inhibitors of enkephalin degrading enzymes: long lasting antinociceptive properties and potentiation by CCK2 antagonist or methadone. Pain. Jul. 2003;104(1-2):139-48.
Tatro, et al. The central melanocortin system and fever. Ann N Y Acad Sci. Jun. 2003;994:246-57.
Wollemann, et al. Non-opioid actions of opioid peptides. Life Sci. Jun. 4, 2004;75(3):257-70.

Affiliated with

Also associated with

Rating

Method of treating condition in animal does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating condition in animal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating condition in animal will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4235714